A detailed history of Candriam S.C.A. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Candriam S.C.A. holds 2,465,714 shares of MRK stock, worth $243 Million. This represents 1.64% of its overall portfolio holdings.

Number of Shares
2,465,714
Previous 2,380,465 3.58%
Holding current value
$243 Million
Previous $295 Million 4.99%
% of portfolio
1.64%
Previous 1.81%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$111.15 - $128.97 $9.48 Million - $11 Million
85,249 Added 3.58%
2,465,714 $280 Million
Q2 2024

Aug 05, 2024

SELL
$123.8 - $132.96 $11.5 Million - $12.3 Million
-92,865 Reduced 3.75%
2,380,465 $295 Million
Q1 2024

May 03, 2024

SELL
$113.24 - $131.95 $63.1 Million - $73.5 Million
-556,959 Reduced 18.38%
2,473,330 $326 Million
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $30.6 Million - $33.3 Million
-305,310 Reduced 9.15%
3,030,289 $330 Million
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $21.6 Million - $24 Million
209,628 Added 6.71%
3,335,599 $343 Million
Q2 2023

Aug 08, 2023

SELL
$108.61 - $118.38 $37.4 Million - $40.7 Million
-344,091 Reduced 9.92%
3,125,971 $361 Million
Q1 2023

May 12, 2023

BUY
$102.94 - $114.86 $27.2 Million - $30.4 Million
264,370 Added 8.25%
3,470,062 $369 Million
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $23.9 Million - $30.6 Million
-272,866 Reduced 7.84%
3,205,692 $356 Million
Q3 2022

Nov 10, 2022

SELL
$84.53 - $94.96 $294,164 - $330,460
-3,480 Reduced 0.1%
3,478,558 $300 Million
Q2 2022

Aug 03, 2022

SELL
$83.49 - $94.64 $4.85 Million - $5.5 Million
-58,091 Reduced 1.64%
3,482,038 $317 Million
Q1 2022

May 13, 2022

BUY
$73.51 - $82.4 $65.2 Million - $73.1 Million
887,274 Added 33.45%
3,540,129 $290 Million
Q4 2021

Feb 10, 2022

SELL
$72.28 - $90.54 $73 Million - $91.5 Million
-1,010,324 Reduced 27.58%
2,652,855 $203 Million
Q3 2021

Nov 09, 2021

SELL
$71.68 - $78.83 $47 Million - $51.6 Million
-655,128 Reduced 15.17%
3,663,179 $275 Million
Q2 2021

Jul 20, 2021

BUY
$70.31 - $77.77 $46.5 Million - $51.5 Million
661,686 Added 18.1%
4,318,307 $336 Million
Q1 2021

Apr 29, 2021

BUY
$68.86 - $81.11 $275 - $324
4 Added 0.0%
3,656,621 $287 Million
Q4 2020

Jan 22, 2021

BUY
$71.77 - $79.65 $51.8 Million - $57.5 Million
722,415 Added 24.62%
3,656,617 $299 Million
Q3 2020

Oct 19, 2020

BUY
$73.18 - $82.95 $65.5 Million - $74.3 Million
895,634 Added 43.93%
2,934,202 $243 Million
Q2 2020

Jul 23, 2020

BUY
$70.42 - $80.13 $45.4 Million - $51.7 Million
644,925 Added 46.28%
2,038,568 $158 Million
Q1 2020

May 26, 2020

BUY
$63.36 - $87.82 $8,173 - $11,328
129 Added 0.01%
1,393,643 $124 Million
Q4 2019

Jan 21, 2020

SELL
$77.58 - $87.54 $13.8 Million - $15.6 Million
-178,360 Reduced 11.35%
1,393,514 $127,000
Q3 2019

Feb 05, 2020

SELL
$76.08 - $82.93 $1,293 - $1,409
-17 Reduced -0.0%
1,571,874 $126 Million
Q3 2019

Oct 21, 2019

SELL
$76.08 - $82.93 $7.99 Million - $8.71 Million
-105,046 Reduced 6.26%
1,571,891 $133,000
Q2 2019

Aug 01, 2019

BUY
$69.84 - $81.59 $8.33 Million - $9.73 Million
119,252 Added 7.66%
1,676,937 $141 Million
Q1 2019

May 02, 2019

BUY
$69.58 - $79.36 $38.8 Million - $44.3 Million
557,628 Added 55.76%
1,557,685 $130 Million
Q4 2018

Feb 14, 2019

SELL
$65.24 - $75.71 $15.8 Million - $18.3 Million
-241,813 Reduced 19.47%
1,000,057 $76.4 Million
Q3 2018

Nov 07, 2018

BUY
$57.69 - $67.84 $47.2 Million - $55.5 Million
817,664 Added 192.75%
1,241,870 $88.1 Million
Q2 2018

Aug 14, 2018

SELL
$50.83 - $59.72 $8.3 Million - $9.75 Million
-163,231 Reduced 27.79%
424,206 $25.8 Million
Q1 2018

May 09, 2018

BUY
$50.96 - $59.23 $2.93 Million - $3.4 Million
57,468 Added 10.84%
587,437 $32 Million
Q4 2017

Feb 07, 2018

SELL
$51.62 - $61.64 $3.24 Million - $3.87 Million
-62,726 Reduced 10.58%
529,969 $29.8 Million
Q3 2017

Nov 03, 2017

BUY
$58.67 - $63.13 $34.8 Million - $37.4 Million
592,695
592,695 $38 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $249B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Candriam S.C.A. Portfolio

Follow Candriam S.C.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.